51³Ô¹ÏÍø

The Making of a COVID-19 Vaccine

The development and production of several life-saving COVID-19 vaccines was a medical miracle, but how did manufacturers manage it? To answer that question, the 51³Ô¹ÏÍø partnered with Emergent BioSolutions on an exclusive series about the company’s accelerated production efforts—which resulted in drug substance to support hundreds of millions of doses in just a few months.

News

What It Takes to Manufacture a Vaccine

March 25, 2021

You may not know it, but one company has the capacity to manufacture bulk drug substance for more than a billion doses of COVID-19 vaccines annually: Emergent BioSolutions, a global supplier for the Johnson & Johnson vaccine and U.S. supplier…